Fortress Biotech, Inc. Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

Investments at Fair Value (Tables)

Investments at Fair Value (Tables)

9 Months Ended

Sep. 30, 2014

Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis

The following table classifies into the fair value hierarchy, financial instruments measured at fair value on a recurring basis in the accompanying Unaudited Condensed Consolidated Balance Sheets as of September 30, 2014; at December 31, 2013, the Company had no investments at fair value:

Fair Value Measurement as of September 30, 2014

($ in thousands)

Level 1

Level 2

Level 3

Total

Long-Term Investment, at fair value

250

Schedule of changes in fair value of financial instruments

The table below provides a rollforward of the changes in fair value of Level 3 financial instruments for the three-months ended September 30, 2014:

	Fair Value of Investment
($ in thousands)	Short-term		Long-term
Balance at June 30, 2014	$	243	$	250
Purchases		50
Change in fair value of investment		(293)
Balance at September 30, 2014	$		$	250

The table below provides a rollforward of the changes in fair value of Level 3 financial instruments for the nine-months ended September 30, 2014:

	Fair Value of Investment
($ in thousands)	Short-term		Long-term
Balance at December 31, 2013	$		$
Purchases		293		250
Change in fair value of investment		(293)
Balance at September 30, 2014	$		$	250